Array BioPharma Inc.

📍 Boulder, United States🗓 Founded 1998👥 125 employees💰 Last funded Jun 2017
Pharmaceutical Manufacturing🌐 arraybiopharma.com
Website LinkedIn
Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1998
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Brazil
1
Frequently asked questions
Who invested in Array BioPharma Inc.?
Array BioPharma Inc. has 1 investors on record on gritt.io.
When did Array BioPharma Inc. last raise funding?
The most recent investment in Array BioPharma Inc. recorded on gritt.io was in June 2017.
When was Array BioPharma Inc. founded?
Array BioPharma Inc. was founded in 1998.
What industry is Array BioPharma Inc. in?
Array BioPharma Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Array BioPharma Inc. based?
Array BioPharma Inc. is headquartered in Boulder, United States.